A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml. [electronic resource]
- The Indian journal of medical research Oct 2011
- 458-62 p. digital
Publication Type: Journal Article
0971-5916
Adult Aged Aged, 80 and over Biomarkers, Tumor--blood Humans Lactoylglutathione Lyase--blood Male Middle Aged Pilot Projects Prognosis Prostate-Specific Antigen--blood Prostatic Neoplasms--blood Thiolester Hydrolases--blood